GE HEALTHCARE INTRODUCES NANOVUE - FAST AND EASY-TO-USE SPECTROPHOTOMETER
 

CHALFONT ST. GILES, UK, March 19, 2008 – GE Healthcare has announced the launch of NanoVue™, a sensitive UV/Visible spectrophotometer that accurately quantifies DNA, RNA, oligo and protein samples and delivers results in under five seconds.

NanoVue’s speed of measurement is due to the system’s proprietary “drop-and-measure” hydrophobic sample plate and user-friendly in-built software. NanoVue does not require a computer and the user can select pre-defined methods or create their own directly from the systems in-built display.

NanoVue’s sensitivity enables measurements of sample volumes as low as 0.5 μl. The system eliminates the use of cuvettes or capillaries, and is extremely easy to clean, reducing the risk of contamination. Users pipette onto the sample plate, with results delivered in under five seconds. Between reads the sample plate can be simply wiped-clean.

Other features include:

• Up to 90 user-defined methods can be stored with password protection

• Optional built-in printer or output data via USB

• Optional wireless connectivity

• User-friendly calibration – without the need to call a GE engineer

• Small foot-print requiring minimum space

To register for a free trial of NanoVue or to find out more information please visit www.gelifesciences.com/tryNanoVue





For a high resolution image please contact us at ge-nanovue@collegehill.com

- ENDS -

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE).Worldwide, GE Healthcare employs more than 47,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com .

Contact

GE Healthcare, Americas
Arvind Gopalratnam
262-501-0777
arvind.gopalratnam@ge.com

GE Healthcare, International
Conor McKechnie
+44 771 751 7028
conor.mckechnie@ge.com

College Hill
Dr Marc Egelhofer, Katie Odgaard, Rebecca Walker
+44 (0)20 7457 2020
ge-nanovue@collegehill.com